Impact of CArdiopulmonary Bypass Flow on Renal Blood Flow, Function and OXygenation

NCT02549066 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Complication of Extracorporeal Circulation
Kidney Circulation Disorder
Renal Function Disorder

Interventions

PROCEDURE: Increased cardiopulmonary bypass flow
DRUG: Milrinone

Sponsor

Sahlgrenska University Hospital